Skip Header

You are using a version of browser that may not display all the features of this website. Please consider upgrading your browser.
Protein

Plasma serine protease inhibitor

Gene

SERPINA5

Organism
Homo sapiens (Human)
Status
Reviewed-Annotation score: Annotation score: 5 out of 5-Experimental evidence at protein leveli

Functioni

Heparin-dependent serine protease inhibitor acting in body fluids and secretions. Inactivates serine proteases by binding irreversibly to their serine activation site. Involved in the regulation of intravascular and extravascular proteolytic activities. Plays hemostatic roles in the blood plasma. Acts as a procoagulant and proinflammatory factor by inhibiting the anticoagulant activated protein C factor as well as the generation of activated protein C factor by the thrombin/thrombomodulin complex. Acts as an anticoagulant factor by inhibiting blood coagulation factors like prothrombin, factor XI, factor Xa, plasma kallikrein and fibrinolytic enzymes such as tissue- and urinary-type plasminogen activators. In seminal plasma, inactivates several serine proteases implicated in the reproductive system. Inhibits the serpin acrosin; indirectly protects component of the male genital tract from being degraded by excessive released acrosin. Inhibits tissue-and urinary-type plasminogen activator, prostate-specific antigen and kallikrein activities; has a control on the sperm motility and fertilization. Inhibits the activated protein C-catalyzed degradation of SEMG1 and SEMG2; regulates the degradation of semenogelin during the process of transfer of spermatozoa from the male reproductive tract into the female tract. In urine, inhibits urinary-type plasminogen activator and kallikrein activities. Inactivates membrane-anchored serine proteases activities such as MPRSS7 and TMPRSS11E. Inhibits urinary-type plasminogen activator-dependent tumor cell invasion and metastasis. May also play a non-inhibitory role in seminal plasma and urine as a hydrophobic hormone carrier by its binding to retinoic acid.18 Publications

Enzyme regulationi

Its inhibitory activity is greatly enhanced in the presence of glycosaminoglycans, heparin, thrombomodulin and phospholipids vesicles.

Sites

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sitei373 – 3742Reactive bond

GO - Molecular functioni

  • acrosin binding Source: UniProtKB
  • glycosaminoglycan binding Source: UniProtKB
  • heparin binding Source: UniProtKB
  • phosphatidylcholine binding Source: UniProtKB
  • protease binding Source: UniProtKB
  • retinoic acid binding Source: UniProtKB
  • serine-type endopeptidase inhibitor activity Source: UniProtKB

GO - Biological processi

  • blood coagulation Source: Reactome
  • fusion of sperm to egg plasma membrane Source: UniProtKB
  • lipid transport Source: UniProtKB-KW
  • negative regulation of hydrolase activity Source: UniProtKB
  • spermatogenesis Source: UniProtKB
Complete GO annotation...

Keywords - Molecular functioni

Protease inhibitor, Serine protease inhibitor

Keywords - Biological processi

Fertilization, Lipid transport, Transport

Keywords - Ligandi

Heparin-binding

Enzyme and pathway databases

ReactomeiR-HSA-140837. Intrinsic Pathway of Fibrin Clot Formation.
R-HSA-140875. Common Pathway of Fibrin Clot Formation.
SABIO-RKP05154.

Protein family/group databases

MEROPSiI04.004.

Names & Taxonomyi

Protein namesi
Recommended name:
Plasma serine protease inhibitor
Alternative name(s):
Acrosomal serine protease inhibitor
Plasminogen activator inhibitor 3
Short name:
PAI-3
Short name:
PAI3
Protein C inhibitor
Short name:
PCI
Serpin A5
Gene namesi
Name:SERPINA5
Synonyms:PCI, PLANH3, PROCI
OrganismiHomo sapiens (Human)
Taxonomic identifieri9606 [NCBI]
Taxonomic lineageiEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo
Proteomesi
  • UP000005640 Componenti: Chromosome 14

Organism-specific databases

HGNCiHGNC:8723. SERPINA5.

Subcellular locationi

GO - Cellular componenti

  • acrosomal membrane Source: UniProtKB
  • external side of plasma membrane Source: UniProtKB
  • extracellular exosome Source: UniProtKB
  • extracellular region Source: UniProtKB
  • extracellular space Source: UniProtKB
  • membrane Source: UniProtKB
  • platelet alpha granule Source: UniProtKB
  • platelet dense tubular network Source: UniProtKB
  • protein C inhibitor-coagulation factor V complex Source: UniProtKB
  • protein C inhibitor-coagulation factor Xa complex Source: UniProtKB
  • protein C inhibitor-coagulation factor XI complex Source: UniProtKB
  • protein C inhibitor-KLK3 complex Source: UniProtKB
  • protein C inhibitor-plasma kallikrein complex Source: UniProtKB
  • protein C inhibitor-PLAT complex Source: UniProtKB
  • protein C inhibitor-PLAU complex Source: UniProtKB
  • protein C inhibitor-thrombin complex Source: UniProtKB
  • protein C inhibitor-TMPRSS11E complex Source: UniProtKB
  • protein C inhibitor-TMPRSS7 complex Source: UniProtKB
  • protein complex Source: UniProtKB
Complete GO annotation...

Keywords - Cellular componenti

Secreted

Pathology & Biotechi

Mutagenesis

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Mutagenesisi248 – 2481R → E: Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Strongly reduces the rate of thrombin inhibition in the presence of heparin. 1 Publication
Mutagenesisi253 – 2531R → E: Inhibits strongly thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 1 Publication
Mutagenesisi272 – 2721E → K: Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 1 Publication
Mutagenesisi274 – 2741K → E: Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 1 Publication
Mutagenesisi285 – 2851K → E: Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 2 Publications
Mutagenesisi288 – 2881R → E: Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 2 Publications
Mutagenesisi289 – 2891K → E: Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Inhibits weakly thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 2 Publications
Mutagenesisi292 – 2921K → E: Does not change the rate of thrombin or activated protein C/F5 inhibition in the presence or absence of heparin. Slightly reduces the rate of thrombin inhibition in the presence of heparin. Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 2 Publications
Mutagenesisi360 – 3601T → R: Inhibits heterodimer formation with TMPRSS11E. 1 Publication
Mutagenesisi371 – 3711T → R: Increases inhibition of activated protein C/F5 and factor XI/F11 activities. Decreases inhibition of thrombin activity. 1 Publication
Mutagenesisi372 – 3721F → P or G: Increases inhibition of thrombin activity. 1 Publication
Mutagenesisi373 – 3731R → P: Increases inhibition of thrombin activity. Inhibits heterodimer formation with TMPRSS11E. 2 Publications
Mutagenesisi376 – 3761R → P: Does not change inhibition of thrombin, activated protein C/F5 and factor XI/F11 activities. 1 Publication
Mutagenesisi381 – 3811R → E: Does not inhibit thrombomodulin-enhanced rate of thrombin inhibition in presence of heparin. 1 Publication

Chemistry

DrugBankiDB00055. Drotrecogin alfa.
DB00013. Urokinase.

Polymorphism and mutation databases

BioMutaiSERPINA5.
DMDMi322510122.

PTM / Processingi

Molecule processing

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Signal peptidei1 – 19191 PublicationAdd
BLAST
Propeptidei20 – 256Removed in mature formPRO_0000414091
Chaini26 – 406381Plasma serine protease inhibitorPRO_0000032427Add
BLAST

Amino acid modifications

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Glycosylationi39 – 391O-linked (GalNAc...)2 Publications
Glycosylationi249 – 2491N-linked (GlcNAc...)2 Publications
Glycosylationi262 – 2621N-linked (GlcNAc...)3 Publications
Glycosylationi338 – 3381N-linked (GlcNAc...)2 Publications

Post-translational modificationi

N- and O-glycosylated. N-glycosylation consists of a mixture of sialylated bi- (including sialyl-Lewis X epitopes), tri- and tetra-antennary complex-type chains; affects the maximal heparin- and thrombomodulin-enhanced rates of thrombin inhibition. O-glycosylated with core 1 or possibly core 8 glycans. Further modified with 2 sialic acid residues.6 Publications
Proteolytically cleaved. Inhibition of proteases is accompanied by formation of a stable enzyme-inhibitor complex and by degradation of the serpin to lower molecular weight derivatives. Proteolytically cleaved at the N-terminus; inhibits slightly the heparin- and thrombomodulin-enhanced rates of thrombin inhibition.2 Publications

Keywords - PTMi

Glycoprotein

Proteomic databases

MaxQBiP05154.
PaxDbiP05154.
PeptideAtlasiP05154.
PRIDEiP05154.

PTM databases

iPTMnetiP05154.
PhosphoSiteiP05154.
UniCarbKBiP05154.

Miscellaneous databases

PMAP-CutDBP05154.

Expressioni

Tissue specificityi

Predominantly expressed in the epithelium of seminal vesicles. Expressed in the proximal tubular epithelium of the kidney. Expressed in the superficial and more differentiated epidermal keratinocytes of the skin. Expressed in megakaryocytes and platelets. Expressed poorly in kidney tumor cells compared to non tumor kidney tissues. Expressed in spermatozoa. Present in very high concentration in seminal plasma. Present in high concentration in plasma, synovial and Graaf follicle fluids. Present in low concentration in breast milk and in amniotic fluids. Present in very low concentration in urine, cerebrospinal fluids, saliva and tears (at protein level). Strongly expressed in liver. Expressed in kidney, spleen, pancreas, skeletal muscle, heart, testes, ovary, interstitial Leydig cells, epididymal glands, seminal vesicles and prostate.7 Publications

Gene expression databases

BgeeiENSG00000188488.
CleanExiHS_SERPINA5.
ExpressionAtlasiP05154. baseline and differential.
GenevisibleiP05154. HS.

Organism-specific databases

HPAiHPA056919.
HPA061957.

Interactioni

Subunit structurei

Forms protease inhibiting heterodimers in extracellular body fluids with serine proteases such as activated protein C/coagulation factor V/F5, acrosin/ACR, chymotrypsinogen B/CTRB1, prothrombin/F2, factor Xa/F10, factor XI/F11, kallikrein/KLKB1, tissue kallikrein, trypsin/PRSS1, prostate specific antigen/KLK3, tissue plasminogen activator/PLAT and urinary plasminogen activator/PLAU. Forms membrane-anchored serine proteases inhibiting heterodimers with TMPRSS7 and TMPRSS11E. Interacts with SEMG2.2 Publications

GO - Molecular functioni

  • acrosin binding Source: UniProtKB
  • protease binding Source: UniProtKB

Protein-protein interaction databases

BioGridi111135. 24 interactions.
DIPiDIP-29869N.
IntActiP05154. 8 interactions.
MINTiMINT-1386269.
STRINGi9606.ENSP00000333203.

Structurei

Secondary structure

1
406
Legend: HelixTurnBeta strand
Show more details
Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Helixi48 – 5912Combined sources
Beta strandi65 – 673Combined sources
Helixi69 – 8113Combined sources
Helixi85 – 9410Combined sources
Helixi101 – 11717Combined sources
Beta strandi123 – 13513Combined sources
Helixi143 – 15311Combined sources
Beta strandi156 – 1594Combined sources
Helixi165 – 17915Combined sources
Turni180 – 1823Combined sources
Beta strandi195 – 21117Combined sources
Helixi215 – 2173Combined sources
Beta strandi219 – 22810Combined sources
Beta strandi230 – 24718Combined sources
Turni248 – 2514Combined sources
Beta strandi252 – 26211Combined sources
Beta strandi264 – 2707Combined sources
Helixi275 – 2817Combined sources
Helixi284 – 29310Combined sources
Beta strandi295 – 30410Combined sources
Beta strandi306 – 3138Combined sources
Helixi314 – 3163Combined sources
Helixi318 – 3214Combined sources
Helixi325 – 3273Combined sources
Turni334 – 3363Combined sources
Beta strandi337 – 3393Combined sources
Beta strandi343 – 35513Combined sources
Beta strandi357 – 37115Combined sources
Beta strandi372 – 3754Combined sources
Beta strandi380 – 3834Combined sources
Beta strandi388 – 40417Combined sources

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
1LQ8X-ray2.40A/C/E/G30-375[»]
B/D/F/H376-406[»]
1PAImodel-A20-373[»]
B374-406[»]
2HI9X-ray2.30A/B/C44-406[»]
2OL2X-ray2.00A/B36-406[»]
2PAImodel-A20-373[»]
B374-406[»]
3DY0X-ray1.55A37-372[»]
B379-406[»]
ProteinModelPortaliP05154.
SMRiP05154. Positions 47-406.
ModBaseiSearch...
MobiDBiSearch...

Miscellaneous databases

EvolutionaryTraceiP05154.

Family & Domainsi

Domaini

The reactive center loop (RCL) extends out from the body of the protein and directs binding to the target protease. The protease cleaves the serpin at the reactive site within the RCL, establishing a covalent linkage between the carboxyl group of the serpin reactive site and the serine hydroxyl of the protease. The resulting inactive serpin-protease complex is highly stable.

Sequence similaritiesi

Belongs to the serpin family.Curated

Keywords - Domaini

Signal

Phylogenomic databases

eggNOGiKOG2392. Eukaryota.
COG4826. LUCA.
GeneTreeiENSGT00760000118839.
HOGENOMiHOG000238521.
HOVERGENiHBG005957.
InParanoidiP05154.
KOiK03913.
OMAiQRIVFNR.
OrthoDBiEOG091G0ION.
PhylomeDBiP05154.
TreeFamiTF343201.

Family and domain databases

InterProiIPR023795. Serpin_CS.
IPR023796. Serpin_dom.
IPR000215. Serpin_fam.
[Graphical view]
PANTHERiPTHR11461. PTHR11461. 1 hit.
PfamiPF00079. Serpin. 1 hit.
[Graphical view]
SMARTiSM00093. SERPIN. 1 hit.
[Graphical view]
SUPFAMiSSF56574. SSF56574. 1 hit.
PROSITEiPS00284. SERPIN. 1 hit.
[Graphical view]

Sequencei

Sequence statusi: Complete.

Sequence processingi: The displayed sequence is further processed into a mature form.

P05154-1 [UniParc]FASTAAdd to basket

« Hide

        10         20         30         40         50
MQLFLLLCLV LLSPQGASLH RHHPREMKKR VEDLHVGATV APSSRRDFTF
60 70 80 90 100
DLYRALASAA PSQSIFFSPV SISMSLAMLS LGAGSSTKMQ ILEGLGLNLQ
110 120 130 140 150
KSSEKELHRG FQQLLQELNQ PRDGFQLSLG NALFTDLVVD LQDTFVSAMK
160 170 180 190 200
TLYLADTFPT NFRDSAGAMK QINDYVAKQT KGKIVDLLKN LDSNAVVIMV
210 220 230 240 250
NYIFFKAKWE TSFNHKGTQE QDFYVTSETV VRVPMMSRED QYHYLLDRNL
260 270 280 290 300
SCRVVGVPYQ GNATALFILP SEGKMQQVEN GLSEKTLRKW LKMFKKRQLE
310 320 330 340 350
LYLPKFSIEG SYQLEKVLPS LGISNVFTSH ADLSGISNHS NIQVSEMVHK
360 370 380 390 400
AVVEVDESGT RAAAATGTIF TFRSARLNSQ RLVFNRPFLM FIVDNNILFL

GKVNRP
Length:406
Mass (Da):45,675
Last modified:February 8, 2011 - v3
Checksum:i2A8FF3DC33C77E04
GO

Experimental Info

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Sequence conflicti28 – 281K → E in CAB45766 (PubMed:17974005).Curated
Sequence conflicti221 – 2211Q → L in AAB26244 (PubMed:8471250).Curated
Sequence conflicti335 – 3351G → R in AAA35688 (PubMed:3027058).Curated
Sequence conflicti335 – 3351G → R in AAB26244 (PubMed:8471250).Curated
Sequence conflicti384 – 3841F → S in AAB26244 (PubMed:8471250).Curated

Natural variant

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifierActions
Natural varianti44 – 441S → G.1 Publication
Corresponds to variant rs2069975 [ dbSNP | Ensembl ].
VAR_013080
Natural varianti55 – 551A → V in allele PCI*B. 3 Publications
Corresponds to variant rs6118 [ dbSNP | Ensembl ].
VAR_007100
Natural varianti64 – 641S → N.9 Publications
Corresponds to variant rs6115 [ dbSNP | Ensembl ].
VAR_013081
Natural varianti94 – 941G → V.1 Publication
Corresponds to variant rs2069976 [ dbSNP | Ensembl ].
VAR_013082
Natural varianti105 – 1051K → E in allele PCI*B. 3 Publications
Corresponds to variant rs6119 [ dbSNP | Ensembl ].
VAR_007101
Natural varianti115 – 1151L → P.1 Publication
Corresponds to variant rs2069999 [ dbSNP | Ensembl ].
VAR_013083
Natural varianti121 – 1211P → A.1 Publication
Corresponds to variant rs6120 [ dbSNP | Ensembl ].
VAR_013900
Natural varianti217 – 2171G → R.2 Publications
Corresponds to variant rs6114 [ dbSNP | Ensembl ].
VAR_013084

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
J02639 mRNA. Translation: AAA35688.1.
M68516 Genomic DNA. Translation: AAA02811.1.
S69366
, S69364, S69574, S69365 Genomic DNA. Translation: AAB30461.1.
U35464 mRNA. Translation: AAB60386.1.
AF361796 Genomic DNA. Translation: AAK27240.1.
AL049839 Genomic DNA. No translation available.
BC008915 mRNA. Translation: AAH08915.1.
S58545 mRNA. Translation: AAB26244.2.
AL080185 mRNA. Translation: CAB45766.1.
CCDSiCCDS9928.1.
PIRiA39339.
RefSeqiNP_000615.3. NM_000624.5.
UniGeneiHs.159628.
Hs.741309.

Genome annotation databases

EnsembliENST00000329597; ENSP00000333203; ENSG00000188488.
ENST00000553780; ENSP00000450837; ENSG00000188488.
ENST00000554276; ENSP00000451610; ENSG00000188488.
ENST00000554866; ENSP00000451126; ENSG00000188488.
GeneIDi5104.
KEGGihsa:5104.
UCSCiuc001ydm.3. human.

Keywords - Coding sequence diversityi

Polymorphism

Cross-referencesi

Web resourcesi

SeattleSNPs

Sequence databases

Select the link destinations:
EMBLi
GenBanki
DDBJi
Links Updated
J02639 mRNA. Translation: AAA35688.1.
M68516 Genomic DNA. Translation: AAA02811.1.
S69366
, S69364, S69574, S69365 Genomic DNA. Translation: AAB30461.1.
U35464 mRNA. Translation: AAB60386.1.
AF361796 Genomic DNA. Translation: AAK27240.1.
AL049839 Genomic DNA. No translation available.
BC008915 mRNA. Translation: AAH08915.1.
S58545 mRNA. Translation: AAB26244.2.
AL080185 mRNA. Translation: CAB45766.1.
CCDSiCCDS9928.1.
PIRiA39339.
RefSeqiNP_000615.3. NM_000624.5.
UniGeneiHs.159628.
Hs.741309.

3D structure databases

Select the link destinations:
PDBei
RCSB PDBi
PDBji
Links Updated
EntryMethodResolution (Å)ChainPositionsPDBsum
1LQ8X-ray2.40A/C/E/G30-375[»]
B/D/F/H376-406[»]
1PAImodel-A20-373[»]
B374-406[»]
2HI9X-ray2.30A/B/C44-406[»]
2OL2X-ray2.00A/B36-406[»]
2PAImodel-A20-373[»]
B374-406[»]
3DY0X-ray1.55A37-372[»]
B379-406[»]
ProteinModelPortaliP05154.
SMRiP05154. Positions 47-406.
ModBaseiSearch...
MobiDBiSearch...

Protein-protein interaction databases

BioGridi111135. 24 interactions.
DIPiDIP-29869N.
IntActiP05154. 8 interactions.
MINTiMINT-1386269.
STRINGi9606.ENSP00000333203.

Chemistry

DrugBankiDB00055. Drotrecogin alfa.
DB00013. Urokinase.

Protein family/group databases

MEROPSiI04.004.

PTM databases

iPTMnetiP05154.
PhosphoSiteiP05154.
UniCarbKBiP05154.

Polymorphism and mutation databases

BioMutaiSERPINA5.
DMDMi322510122.

Proteomic databases

MaxQBiP05154.
PaxDbiP05154.
PeptideAtlasiP05154.
PRIDEiP05154.

Protocols and materials databases

DNASUi5104.
Structural Biology KnowledgebaseSearch...

Genome annotation databases

EnsembliENST00000329597; ENSP00000333203; ENSG00000188488.
ENST00000553780; ENSP00000450837; ENSG00000188488.
ENST00000554276; ENSP00000451610; ENSG00000188488.
ENST00000554866; ENSP00000451126; ENSG00000188488.
GeneIDi5104.
KEGGihsa:5104.
UCSCiuc001ydm.3. human.

Organism-specific databases

CTDi5104.
GeneCardsiSERPINA5.
H-InvDBHIX0079547.
HGNCiHGNC:8723. SERPINA5.
HPAiHPA056919.
HPA061957.
MIMi601841. gene.
neXtProtiNX_P05154.
GenAtlasiSearch...

Phylogenomic databases

eggNOGiKOG2392. Eukaryota.
COG4826. LUCA.
GeneTreeiENSGT00760000118839.
HOGENOMiHOG000238521.
HOVERGENiHBG005957.
InParanoidiP05154.
KOiK03913.
OMAiQRIVFNR.
OrthoDBiEOG091G0ION.
PhylomeDBiP05154.
TreeFamiTF343201.

Enzyme and pathway databases

ReactomeiR-HSA-140837. Intrinsic Pathway of Fibrin Clot Formation.
R-HSA-140875. Common Pathway of Fibrin Clot Formation.
SABIO-RKP05154.

Miscellaneous databases

ChiTaRSiSERPINA5. human.
EvolutionaryTraceiP05154.
GeneWikiiProtein_C_inhibitor.
GenomeRNAii5104.
PMAP-CutDBP05154.
PROiP05154.
SOURCEiSearch...

Gene expression databases

BgeeiENSG00000188488.
CleanExiHS_SERPINA5.
ExpressionAtlasiP05154. baseline and differential.
GenevisibleiP05154. HS.

Family and domain databases

InterProiIPR023795. Serpin_CS.
IPR023796. Serpin_dom.
IPR000215. Serpin_fam.
[Graphical view]
PANTHERiPTHR11461. PTHR11461. 1 hit.
PfamiPF00079. Serpin. 1 hit.
[Graphical view]
SMARTiSM00093. SERPIN. 1 hit.
[Graphical view]
SUPFAMiSSF56574. SSF56574. 1 hit.
PROSITEiPS00284. SERPIN. 1 hit.
[Graphical view]
ProtoNetiSearch...

Entry informationi

Entry nameiIPSP_HUMAN
AccessioniPrimary (citable) accession number: P05154
Secondary accession number(s): Q07616, Q9UG30
Entry historyi
Integrated into UniProtKB/Swiss-Prot: August 13, 1987
Last sequence update: February 8, 2011
Last modified: September 7, 2016
This is version 187 of the entry and version 3 of the sequence. [Complete history]
Entry statusiReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Miscellaneousi

Keywords - Technical termi

3D-structure, Complete proteome, Direct protein sequencing, Reference proteome

Documents

  1. Human chromosome 14
    Human chromosome 14: entries, gene names and cross-references to MIM
  2. Human entries with polymorphisms or disease mutations
    List of human entries with polymorphisms or disease mutations
  3. Human polymorphisms and disease mutations
    Index of human polymorphisms and disease mutations
  4. MIM cross-references
    Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
  5. PDB cross-references
    Index of Protein Data Bank (PDB) cross-references
  6. SIMILARITY comments
    Index of protein domains and families

Similar proteinsi

Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:
100%UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry.
90%UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence).
50%UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster.